Black Friday saleUp to 70% OFF
III

INITIATOR PHARMA A/S

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

INIT chart


Full chart

Key stats


Market capitalization
‪342.02 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.35 SEK
Net income (FY)
‪−35.23 M‬ SEK
Revenue (FY)
0.00 SEK
Shares float
—
Beta (1Y)
−0.11

Employees


Employees (FY)
3
Change (1Y)
0
Revenue / Employee (1Y)
0.00 SEK
Net income / Employee (1Y)
‪−1.16 M‬ SEK

About INITIATOR PHARMA A/S


Sector
Health Technology
CEO
Claus Elsborg Olesen
Headquarters
Copenhagen
Website
initiatorpharma.com
Founded
2016
ISIN
DK0060775872
FIGI
BBG00F8TQYG4
Initiator Pharma A/S is a clinical-stage biotechnology company, which engages in the development of novel therapeutics within the field of mono-amine reuptake transporters targeting central nervous system (CNS)-disorders. Its portfolio consists of IPED2015, represents a novel treatment paradigm for the treatment of organic erectile dysfunction (ED); and IP2018, a drug candidate for the treatment of psychogenic ED and depression. The company was founded by Claus Elsborg Olesen, Dan Peters, Ulf Simonsen, and Mikael Sondergaard Thomsen in 2016 and is headquartered in Copenhagen, Denmark.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

INIT news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of INIT is 6.55 SEK — it has increased by 1.55% in the past 24 hours. Watch INITIATOR PHARMA A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange INITIATOR PHARMA A/S stocks are traded under the ticker INIT.
INIT stock has fallen by −5.07% compared to the previous week, the month change is a −7.75% fall, over the last year INITIATOR PHARMA A/S has showed a −30.17% decrease.
We've gathered analysts' opinions on INITIATOR PHARMA A/S future price: according to them, INIT price has a max estimate of 24.59 SEK and a min estimate of 24.59 SEK. Watch INIT chart and read a more detailed INITIATOR PHARMA A/S stock forecast: see what analysts think of INITIATOR PHARMA A/S and suggest that you do with its stocks.
INIT reached its all-time high on Oct 6, 2023 with the price of 12.20 SEK, and its all-time low was 2.60 SEK and was reached on May 31, 2017. View more price dynamics on INIT chart.
See other stocks reaching their highest and lowest prices.
INIT stock is 9.23% volatile and has beta coefficient of −0.11. Track INITIATOR PHARMA A/S stock price on the chart and check out the list of the most volatile stocks — is INITIATOR PHARMA A/S there?
Today INITIATOR PHARMA A/S has the market capitalization of ‪342.02 M‬, it has decreased by −1.48% over the last week.
Yes, you can track INITIATOR PHARMA A/S financials in yearly and quarterly reports right on TradingView.
INIT net income for the last quarter is ‪−7.38 M‬ SEK, while the quarter before that showed ‪−6.24 M‬ SEK of net income which accounts for −18.34% change. Track more INITIATOR PHARMA A/S financial stats to get the full picture.
No, INIT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 3.00 employees. See our rating of the largest employees — is INITIATOR PHARMA A/S on this list?
Like other stocks, INIT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INITIATOR PHARMA A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INITIATOR PHARMA A/S technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INITIATOR PHARMA A/S stock shows the sell signal. See more of INITIATOR PHARMA A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.